このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Vicarious Surgical 将来の成長

Future 基準チェック /06

Vicarious Surgicalの収益は年間4.1%で減少すると予測されていますが、年間収益は年間62.3%で増加すると予測されています。EPS は年間増加すると予測されています。自己資本利益率は 3 年後に-116.9% 0.6%なると予測されています。

主要情報

-4.1%

収益成長率

0.6%

EPS成長率

Medical Equipment 収益成長	16.6%
収益成長率	62.3%
将来の株主資本利益率	-116.9%
アナリストカバレッジ	Low
最終更新日	30 Apr 2024

今後の成長に関する最新情報

Recent updates

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Mar 05

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Nov 24

Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization

Aug 24

業績と収益の成長予測

NYSE:RBOT - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	N/A	-79	N/A	N/A	3
12/31/2025	N/A	-75	N/A	N/A	3
12/31/2024	N/A	-67	N/A	N/A	3
3/31/2024	N/A	-61	-60	-58	N/A
12/31/2023	N/A	-71	-64	-62	N/A
9/30/2023	N/A	-69	-71	-69	N/A
6/30/2023	N/A	-78	-68	-66	N/A
3/31/2023	N/A	-64	-69	-65	N/A
12/31/2022	N/A	5	-67	-61	N/A
9/30/2022	N/A	38	-58	-53	N/A
6/30/2022	N/A	18	-57	-52	N/A
3/31/2022	N/A	13	-47	-44	N/A
12/31/2021	N/A	-35	-35	-33	N/A
9/30/2021	N/A	-61	-28	-27	N/A
6/30/2021	N/A	-19	-17	-16	N/A
3/31/2021	N/A	-15	-14	-14	N/A
12/31/2020	N/A	-13	-12	-12	N/A

アナリストによる今後の成長予測

収入対貯蓄率: RBOT今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: RBOT今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: RBOT今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: RBOT来年は収益がないと予測されています。

高い収益成長: RBOT来年は収益がないと予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: RBOT 3 年以内に赤字になると予測されています。

Vicarious Surgical 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Price target decreased by 84% to US$1.13

Price target decreased by 21% to US$7.75

Price target decreased to US$11.80

Recent updates

Vicarious Surgical Inc., Annual General Meeting, Jun 10, 2024

Vicarious Surgical Inc. to Report Q1, 2024 Results on Apr 29, 2024

New major risk - Revenue and earnings growth

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Vicarious Surgical Inc. to Report Q4, 2023 Results on Mar 04, 2024

Vicarious Surgical Inc. Announces Management Changes

Vicarious Surgical Inc. Announces Appointment of Randy Clark as President Effective, January 29, 2024

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Price target decreased by 84% to US$1.13

Vicarious Surgical Inc. to Report Q3, 2023 Results on Nov 13, 2023

New minor risk - Market cap size

Vicarious Surgical Receives Continued Listing Standard Notice From NYSE

Vicarious Surgical Receives Continued Listing Standard Notice From NYSE

Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization

New minor risk - Share price stability

Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation

Vicarious Surgical Inc. to Report Q2, 2023 Results on Jul 27, 2023

New minor risk - Insider selling

Co-Founder recently sold US$54k worth of stock

Vicarious Surgical: Cash Burn Adds To Downside Risk

Co-Founder notifies of intention to sell stock

Vicarious Surgical Inc. Announces Promotion of John Mazzola to Chief Operating Officer

Insider recently bought US$153k worth of stock

Investor sentiment deteriorates as stock falls 21%

Insider recently bought US$139k worth of stock

Insider recently bought US$78k worth of stock

Co-Founder recently sold US$65k worth of stock

Co-Founder notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 15%

Price target decreased by 21% to US$7.75

Insider recently bought US$241k worth of stock

Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02

Investor sentiment improves as stock rises 17%

Vicarious Surgical Inc. to Report Q4, 2022 Results on Feb 13, 2023

Vicarious Surgical Inc. Announces Changes to Board of Directors

Investor sentiment improved over the past week

Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Co-Founder recently sold US$74k worth of stock

High number of new and inexperienced directors

Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03

Investor sentiment improved over the past week

Vicarious Surgical Inc. to Report Q3, 2022 Results on Nov 07, 2022

CFO & Treasurer notifies of intention to sell stock

Vicarious Surgical Inc. Announces Changes to Board of Directors

Independent Director recently sold US$54k worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Independent Director recently sold US$87k worth of stock

Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02

Vicarious Surgical Inc. to Report Q2, 2022 Results on Aug 08, 2022

Investor sentiment improved over the past week

Vectoring In On Vicarious Surgical Inc.

Investor sentiment improved over the past week

Independent Director recently sold US$119k worth of stock

Investor sentiment improved over the past week

Independent Director recently sold US$169k worth of stock

High number of new and inexperienced directors

Vicarious Surgical Inc., Annual General Meeting, Jun 01, 2022

Price target decreased to US$11.80

Vicarious Surgical Inc. to Report Q1, 2022 Results on May 09, 2022

Vicarious Surgical Inc. to Report Q4, 2021 Results on Mar 03, 2022

Vicarious Surgical: Developing Minimally Invasive VR Surgical System

No independent directors

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘